人工智能独立用于数字乳腺X线摄影和数字乳腺断层合成筛查的回顾性评估
本研究回顾性评估人工智能系统独立阅读数字乳腺X线摄影(DM)和数字乳腺断层合成(DBT)筛查影像的性能。AI对DM的AUC为0.93,对DBT的AUC为0.94;AI作为单读或双读时敏感度非劣于人类阅读,DM召回率降低而DBT召回率升高。
要点
- AI独立阅读DM的AUC为0.93(95%CI:0.89,0.96),DBT为0.94(95%CI:0.91,0.97)。
- DM中AI单读敏感度58.4%(66/113)非劣于人类,召回率降低最多2%。
- DBT中AI单读敏感度77%(87/113)非劣于人类,但召回率升高最多12.3%。
核心结论
- 人工智能可能替代放射科医生进行乳腺筛查阅读,实现非劣效敏感度,DM召回率更低但DBT召回率更高。
研究设计与样本
- 回顾性收集2015年1月至2016年12月Tomosynthesis Cordoba筛查试验中连续配对独立阅读的DM和DBT影像,共15999次检查(113例乳腺癌,包括98例筛查检出和15例间期癌),来自15998名女性(平均年龄58岁±6)。
诊断标准与关键数值
- AI系统独立计算DM和DBT的癌症风险评分(范围1-100);AI独立性能用AUC及不同操作点的敏感度和召回率衡量,操作点选择为与人类阅读相比敏感度非劣效(非劣效界值5%)。
临床应用与阅片要点
- AI作为独立阅读者时,DM召回率降低(P<.001)最多2%(95%CI:-2.4,-1.6),DBT召回率升高(P<.001)最多12.3%(95%CI:11.7,12.9);DM单读敏感度58.4%(66/113;95%CI:49.2,67.1),双读67.3%(76/113;95%CI:58.2,75.2);DBT单读敏感度77%(87/113;95%CI:68.4,83.8),双读81.4%(92/113;95%CI:73.3,87.5)。
局限性
- 本文为回顾性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Use of artificial intelligence (AI) as a stand-alone reader for digital mammography (DM) or digital breast tomosynthesis (DBT) breast screening could ease radiologists' workload while maintaining quality. Purpose To retrospectively evaluate the stand-alone performance of an AI system as an independent reader of DM and DBT screening examinations. Materials and Methods Consecutive screening-paired and independently read DM and DBT images acquired between January 2015 and December 2016 were retrospectively collected from the Tomosynthesis Cordoba Screening Trial. An AI system computed a cancer risk score (range, 1-100) for DM and DBT examinations independently. AI stand-alone performance was measured using the area under the receiver operating characteristic curve (AUC) and sensitivity and recall rate at different operating points selected to have noninferior sensitivity compared with the human readings (noninferiority margin, 5%). The recall rate of AI and the human readings were compared using a McNemar test. Results A total of 15 999 DM and DBT examinations (113 breast cancers, including 98 screen-detected and 15 interval cancers) from 15 998 women (mean age, 58 years ± 6 [standard deviation]) were evaluated. AI achieved an AUC of 0.93 (95% CI: 0.89, 0.96) for DM and 0.94 (95% CI: 0.91, 0.97) for DBT. For DM, AI achieved noninferior sensitivity as a single (58.4%; 66 of 113; 95% CI: 49.2, 67.1) or double (67.3%; 76 of 113; 95% CI: 58.2, 75.2) reader, with a reduction in recall rate (P < .001) of up to 2% (95% CI: -2.4, -1.6). For DBT, AI achieved noninferior sensitivity as a single (77%; 87 of 113; 95% CI: 68.4, 83.8) or double (81.4%; 92 of 113; 95% CI: 73.3, 87.5) reader, but with a higher recall rate (P < .001) of up to 12.3% (95% CI: 11.7, 12.9). Conclusion Artificial intelligence could replace radiologists' readings in breast screening, achieving a noninferior sensitivity, with a lower recall rate for digital mammography but a higher recall rate for digital breast tomosynthesis. Published under a CC BY 4.0 license. See also the editorial by Fuchsjäger and Adelsmayr in this issue.
引用
- Romero-Martín, Elías-Cabot, Raya-Povedano, et al. Stand-Alone Use of Artificial Intelligence for Digital Mammography and Digital Breast Tomosynthesis Screening: A Retrospective Evaluation. Radiology. 2021. PMID: 34904872. doi:10.1148/radiol.211590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。